| SC 13G/A | 2024-02-14 | Point72 Asset Management, L.P. | Cidara Therapeutics, Inc. | 1,250,000 | 1.4% | EDGAR |
| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | Cidara Therapeutics, Inc. | 4,998,161 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-14 | Nantahala Capital Management, LLC | Cidara Therapeutics, Inc. | 1,546,745 | 1.7% | EDGAR |
| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Cidara Therapeutics, Inc. | 3,868,006 | 5.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Nantahala Capital Management, LLC | Cidara Therapeutics, Inc. | 4,367,464 | 6.1% | EDGAR |
| SC 13G/A | 2022-02-15 | LYTTON LAURENCE W | Cidara Therapeutics, Inc. | 1,708,328 | 2.5% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Cidara Therapeutics, Inc. | 4,200,000 | 6.3% | EDGAR |
| SC 13G/A | 2022-02-14 | Omega Fund V, L.P. | Cidara Therapeutics, Inc. | 1,249,999 | 1.8% | EDGAR |
| SC 13G | 2022-02-14 | Nantahala Capital Management, LLC | Cidara Therapeutics, Inc. | 5,270,458 | 7.9% | EDGAR |
| SC 13G/A | 2022-02-11 | BB BIOTECH AG | Cidara Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-12-16 | BIOTECHNOLOGY VALUE FUND L P | Cidara Therapeutics, Inc. | 2,583,761 | 3.9% | EDGAR |
| SC 13G | 2021-10-14 | Point72 Asset Management, L.P. | Cidara Therapeutics, Inc. | 4,200,000 | 6.3% | EDGAR |
| SC 13D/A | 2021-08-12 | INTERWEST PARTNERS X LP | Cidara Therapeutics, Inc. | 903,739 | 1.9% | EDGAR |
| SC 13G/A | 2021-03-08 | LYTTON LAURENCE W | Cidara Therapeutics, Inc. | 3,340,400 | 7.0% | EDGAR |
| SC 13G | 2021-03-05 | LYTTON LAURENCE W | Cidara Therapeutics, Inc. | 2,727,072 | 5.7% | EDGAR |
| SC 13G/A | 2021-02-16 | 5AM VENTURES III, L.P. | Cidara Therapeutics, Inc. | 1,956,099 | 4.5% | EDGAR |
| SC 13G/A | 2021-02-12 | BIOTECHNOLOGY VALUE FUND L P | Cidara Therapeutics, Inc. | 2,175,628 | 4.9% | EDGAR |
| SC 13G/A | 2021-02-12 | Stonepine Capital Management, LLC | Cidara Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Omega Fund V, L.P. | Cidara Therapeutics, Inc. | 3,255,248 | 7.2% | EDGAR |
| SC 13G/A | 2021-02-12 | BB BIOTECH AG | Cidara Therapeutics, Inc. | 2,822,495 | 6.4% | EDGAR |